Inogen (INGN) Net Income towards Common Stockholders (2013 - 2026)
Inogen (INGN) reported Net Income towards Common Stockholders of -$8.3 million for Q1 2026, down 34.82% year-over-year from -$12.8 million in Q1 2025, and down 1.95% on a QoQ basis from -$8.2 million in Q4 2025.
Inogen (INGN) has 14 years of Net Income towards Common Stockholders data on file, last reported at -$8.3 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 34.82% year-over-year to -$8.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$25.9 million (down 22.56% YoY) and the FY2025 annual result came in at -$23.8 million, up 19.55% from the prior year.
- Net Income towards Common Stockholders retreated to -$8.3 million in Q1 2026 per INGN's latest filing, from -$8.2 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $27.8 million in Q4 2022 and bottomed at -$45.7 million in Q3 2023.
- The 5-year median for Net Income towards Common Stockholders is -$8.2 million (2025), against an average of -$9.6 million.
- Peak annual rise in Net Income towards Common Stockholders reached 273.36% in 2022, while the deepest fall reached 1841.8% in 2022.
- Tracing INGN's Net Income towards Common Stockholders over 5 years: stood at $27.8 million in 2022, then tumbled by 196.38% to -$26.8 million in 2023, then jumped by 87.19% to -$3.4 million in 2024, then plunged by 137.77% to -$8.2 million in 2025, then slipped by 1.95% to -$8.3 million in 2026.
- Per Business Quant, the three latest INGN Net Income towards Common Stockholders figures stand at -$8.3 million (Q1 2026), -$8.2 million (Q4 2025), and -$5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | -8.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.32 Mn |
| Dec 31, 2025 | -8.17 Mn |
| Sep 30, 2025 | -5.29 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -3.43 Mn |
| Sep 30, 2024 | -5.96 Mn |
| Jun 30, 2024 | -5.59 Mn |
| Mar 31, 2024 | -14.58 Mn |
| Dec 31, 2023 | -26.81 Mn |
| Sep 30, 2023 | -45.72 Mn |
| Jun 30, 2023 | -9.83 Mn |
| Mar 31, 2023 | -20.35 Mn |
| Dec 31, 2022 | 27.81 Mn |
| Sep 30, 2022 | -9.51 Mn |
| Jun 30, 2022 | -3.44 Mn |
| Mar 31, 2022 | -14.21 Mn |
| Dec 31, 2021 | -16.04 Mn |
| Sep 30, 2021 | 12.17 Mn |
| Jun 30, 2021 | 5.10 Mn |
| Mar 31, 2021 | -732,000.00 |
| Dec 31, 2020 | -5.12 Mn |
| Sep 30, 2020 | -1.70 Mn |
| Jun 30, 2020 | 2.58 Mn |
| Mar 31, 2020 | -1.59 Mn |
| Dec 31, 2019 | -1.38 Mn |
| Sep 30, 2019 | 6.86 Mn |
| Jun 30, 2019 | 10.16 Mn |
| Mar 31, 2019 | 5.30 Mn |
| Dec 31, 2018 | 10.05 Mn |
| Sep 30, 2018 | 16.43 Mn |
| Jun 30, 2018 | 14.61 Mn |
| Mar 31, 2018 | 10.76 Mn |
| Dec 31, 2017 | -606,000.00 |
| Sep 30, 2017 | 7.34 Mn |
| Jun 30, 2017 | 8.34 Mn |
| Mar 31, 2017 | 5.93 Mn |
| Dec 31, 2016 | 5.26 Mn |
| Sep 30, 2016 | 5.25 Mn |
| Jun 30, 2016 | 7.49 Mn |
| Mar 31, 2016 | 2.52 Mn |
| Dec 31, 2015 | 3.86 Mn |
| Sep 30, 2015 | 2.70 Mn |
| Jun 30, 2015 | 3.46 Mn |
| Mar 31, 2015 | 1.57 Mn |
| Dec 31, 2014 | 1.52 Mn |
| Sep 30, 2014 | 2.13 Mn |
| Jun 30, 2014 | 2.29 Mn |
| Mar 31, 2014 | -99,000.00 |
| Dec 31, 2013 | 21.97 Mn |
| Sep 30, 2013 | -1.08 Mn |
| Jun 30, 2013 | 1.79 Mn |
| Mar 31, 2013 | 730,000.00 |